Knight Therapeutics | GUD - Ebit

金融业

CAD

CAD 1.05B

现金及等价物

CAD 76.45M

CAD 82.22M

CAD 394.84M

CAD 165.26M

CAD 77.91M

CAD 6.21M

CAD 24.45M

698

EPS每股收益

CAD 0.13

股本和储备

CAD 767.27M

CAD 64.72M

债务利息支出

CAD 3.92M

CAD 2.46M

CAD 57.78M

CAD 930.77M

CAD -3.79M

CAD 126.9M

CAD 6.21M

普通股股本

CAD 99.68M

257.34

CAD -1.92M

CAD 133.11M

销售和管理费用

CAD 35.45M

CAD 95.4M

贸易债权人

CAD 125.76M

应收帐款人

CAD 183M

	Ebit	更改		日
Acasti Pharma	USD -3.7M		1.13M	2024-12
Akebia Therapeutics	USD -5.45M		9.4M	2025-12
Alaunos Therapeutics	USD -1.01M		175K	2026-03
Aurora Cannabis	CAD -35.79M		8.96M	2025-12
Avita Medical	AUD -10.39M		1.72M	2025-12
Canopy Growth	CAD -12.66M		1.64M	2025-12
Cronos Group	USD -1.45M		5.61M	2026-03
Dianthus Therapeutics	USD -69.54M		29.25M	2025-12
Ionis Pharmaceuticals	USD -118M		97M	2026-03
IQVIA Holdings	USD 565M		2.11B	2026-03
Knight Therapeutics	CAD 6.21M		3.27M	2025-12
Moderna	USD -1.39B		531M	2026-03
Omeros	USD -48.15M		7.25M	2023-09
Organigram Holdings	CAD -20.13M		7.92M	2025-12
Organon & Co	USD -27M		415M	2025-12
Revvity	USD 82.77M		63.06M	2026-03
Tectonic Therapeutic	USD -21.52M		374K	2025-12
Tilray	USD -20.01M		9.34M	2025-09
Viatris	USD -20.2M		137.3M	2026-03
Xeris Pharmaceuticals	USD 16.77M		8.88M	2025-12